Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Zealand Allows Clinics To Dose Isotane For Acne

This article was originally published in PharmAsia News

Executive Summary

Skin-care treatment centers in New Zealand moved quickly to take advantage of a decision by the Pharmaceutical Management Agency of New Zealand to allow coverage of broader sales of Pacific Pharmaceuticals' Isotane (isotretinoin). The Skin Institute and others had anticipated PHARMAC's decision to expand the authority to write prescriptions for the anti-acne drug beyond physician offices. The institute, a national skincare chain, had pressed for approving acne clinics to prescribe the drugs, citing equity-of-access issues. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070862

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel